The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Theravance Biopharma, Inc(NASDAQ:TBPH) 
Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and commercializes organ-selective medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstr...
Website: http://www.theravance.com
Founded: 2013
Full Time Employees: 316
Sector: Healthcare
Industry: Biotechnology
Theravance Biopharma Days Payable Outstanding ttm (DPO)
Theravance Biopharma Days Receivable Outstanding ttm (DSO)
Theravance Biopharma Op Cashflow Per Share ttm
Theravance Biopharma Free Cashflow Per Share ttm
Theravance Biopharma Cash Per Share ttm
Theravance Biopharma P/S ratio ttm
Theravance Biopharma (GAAP) P/E ratio ttm
Theravance Biopharma P/B ratio ttm
No extra charts and metrics for this ticker.